Nelfinavir Mesylate Patent Expiration
Nelfinavir Mesylate is Used for managing HIV infection. It was first introduced by Agouron Pharmaceuticals Llc
Nelfinavir Mesylate Patents
Given below is the list of patents protecting Nelfinavir Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Viracept |
US5484926 (Pediatric) | HIV protease inhibitors |
Apr 07, 2014
(Expired) | Agouron Pharms |
| Viracept |
US5952343 (Pediatric) | HIV protease inhibitors |
Apr 07, 2014
(Expired) | Agouron Pharms |
| Viracept |
US6162812 (Pediatric) | Pharmaceutical compositions containing HIV protease inhibitors and methods of their use |
Apr 07, 2014
(Expired) | Agouron Pharms |
| Viracept | US5484926 | HIV protease inhibitors |
Oct 07, 2013
(Expired) | Agouron Pharms |
| Viracept | US5952343 | HIV protease inhibitors |
Oct 07, 2013
(Expired) | Agouron Pharms |
| Viracept | US6162812 | Pharmaceutical compositions containing HIV protease inhibitors and methods of their use |
Oct 07, 2013
(Expired) | Agouron Pharms |
Nelfinavir Mesylate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List